| Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer P Pal, K Hales, J Petrik, DB Hales Journal of Ovarian Research 12, 1-16, 2019 | 45 | 2019 |
| Emerging roles of ceramides in breast cancer biology and therapy P Pal, GE Atilla-Gokcumen, J Frasor International Journal of Molecular Sciences 23 (19), 11178, 2022 | 20 | 2022 |
| A review of principal studies on the development and treatment of epithelial ovarian cancer in the laying hen Gallus gallus P Pal, KN Starkweather, KH Hales, DB Hales Comparative Medicine 71 (4), 271-284, 2021 | 13 | 2021 |
| Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells SE Semina, P Pal, NS Kansara, RJ Huggins, ET Alarid, GL Greene, ... Breast Cancer Research 24 (1), 19, 2022 | 10 | 2022 |
| Endocrine therapy-resistant breast cancer cells are more sensitive to ceramide kinase inhibition and elevated ceramide levels than therapy-sensitive breast cancer cells P Pal, A Millner, SE Semina, RJ Huggins, L Running, DS Aga, DA Tonetti, ... Cancers 14 (10), 2380, 2022 | 6 | 2022 |
| The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling P Pal, K Hales, DB Hales Oncotarget 11 (40), 3646, 2020 | 6 | 2020 |
| Structural analysis of sigma E interactions with core RNA polymerase and its cognate P-hsp20 promoter of Mycobacterium tuberculosis AM Gupta, P Pal, S Mandal Journal of Biomolecular Structure and Dynamics 34 (4), 792-799, 2016 | 3 | 2016 |
| Abstract P4-02-06: Exploiting ceramide homeostasis to target endocrine therapy-resistant breast cancer P Pal, A Millner, E Atilla-Gokcumen, J Frasor Cancer Research 82 (4_Supplement), P4-02-06-P4-02-06, 2022 | | 2022 |
| Dietary flaxseed supplementation in ovarian cancer: Elucidating the molecular actions of its biologically derived active compounds. P Pal, K Hales, DB Hales CLINICAL CANCER RESEARCH 26 (13), 97-97, 2020 | | 2020 |
| Abstract B35: Dietary flaxseed supplementation in ovarian cancer: Elucidating the molecular actions of its biologically derived active compounds P Pal, K Hales, DB Hales Clinical Cancer Research 26 (13_Supplement), B35-B35, 2020 | | 2020 |
| Elucidating the Molecular Mechanisms of the Anti-Cancer Actions of a Flaxseed-Supplemented Diet Against Ovarian Cancer P Pal Southern Illinois University at Carbondale, 2020 | | 2020 |
| Beauty of the Pyramid P Pal NISCAIR-CSIR, India, 2012 | | 2012 |
G. Ekin Atilla GokcumenProfessor of Chemistry, University at Buffalo在 buffalo.edu 的电子邮件经过验证
